Several brain regions, including the medial prefrontal cortex (mPFC), are important in the process of fear extinction learning. Ketamine is a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist, which is shown to play a role in extinction modulation. Ketamine and calcineurin (CN), an intracellular protein phosphatase, have several common targets in the cells. Therefore, in the present study, our aim is to investigate the possible role of calcineurin in the mPFC on the enhancing effects of ketamine in fear extinction. First, different doses of a CN inhibitor, cyclosporine-A (CsA), were micro-injected into the infralimbic (IL) region of the mPFC prior to extinction training in a classical conditioning model in rats. Next, sub-effective doses of CsA (Intra-mPFC) and ketamine (i.p.) were co-administered in another cohort of rats to find their possible interactions. Enzymatic activity of calcineurin was measured in the IL-mPFC following drug administration. We used the elevated plus-maze (EPM) and open field (OF) test for further behavioral assessments. The results showed that CsA can enhance the extinction of conditioned fear and inhibit the enzyme CN at a dose of 20 nM. The combination of sub-effective doses of CsA (5 nM) and ketamine (10 mg/kg) could again enhance the extinction of fear and reduce CN activity in the region. Our results propose that inhibition of CN in the IL-mPFC is involved in the extinction of fear and ketamine enhancement of extinction is probably mediated by reducing CN activity in this part of the brain.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Availability of data and materials
Data available upon reasonable request.
Almeida-Corrêa S, Moulin TC, Carneiro CF, Gonçalves MM, Junqueira LS, Amaral OB (2015) Calcineurin inhibition blocks within-, but not between-session fear extinction in mice. Learn Mem 22:159–169
Amat J, Dolzani SD, Tilden S et al (2016) Previous ketamine produces an enduring blockade of neurochemical and behavioral effects of uncontrollable stress. J Neurosci 36:153–161. https://doi.org/10.1523/JNEUROSCI.3114-15.2016
Autry AE, Adachi M, Nosyreva E et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91–95. https://doi.org/10.1038/nature10130
Babar E, Ozgunen T, Melik E, Polat S, Akman H (2001) Effects of ketamine on different types of anxiety/fear and related memory in rats with lesions of the median raphe nucleus. Eur J Pharmacol 431:315–320. https://doi.org/10.1016/s0014-2999(01)01340-1
Bouton ME (2004) Context and behavioral processes in extinction. Learn Mem 11:485–494
Cleva RM, Gass JT, Widholm JJ, Olive MF (2010) Glutamatergic targets for enhancing extinction learning in drug addiction. Curr Neuropharmacol 8:394–408. https://doi.org/10.2174/157015910793358169
D’Andrea D, Andrew Sewell R (2013) Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion. Biol Psychiatry 74:e13-14. https://doi.org/10.1016/j.biopsych.2013.04.019
de la Fuente V, Freudenthal R, Romano A (2011) Reconsolidation or extinction: transcription factor switch in the determination of memory course after retrieval. J Neurosci 31:5562–5573. https://doi.org/10.1523/JNEUROSCI.6066-10.2011
Donoghue AC, Roback MG, Cullen KR (2015) Remission from behavioral dysregulation in a child with PTSD after receiving procedural ketamine. Pediatrics 136:e694-696. https://doi.org/10.1542/peds.2014-4152
Engin E, Treit D, Dickson CT (2009) Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience 161:359–369. https://doi.org/10.1016/j.neuroscience.2009.03.038
Farinelli M, Deschaux O, Hugues S, Thevenet A, Garcia R (2006) Hippocampal train stimulation modulates recall of fear extinction independently of prefrontal cortex synaptic plasticity and lesions. Learn Mem 13:329–334. https://doi.org/10.1101/lm.204806
Feder A, Parides MK, Murrough JW et al (2014) Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71:681–688. https://doi.org/10.1001/jamapsychiatry.2014.62
Fitzgerald JM, DiGangi JA, Phan KL (2018) Functional neuroanatomy of emotion and its regulation in PTSD. Harv Rev Psychiatry 26:116–128. https://doi.org/10.1097/HRP.0000000000000185
Fraga DB, Olescowicz G, Moretti M et al (2018) Anxiolytic effects of ascorbic acid and ketamine in mice. J Psychiatr Res 100:16–23. https://doi.org/10.1016/j.jpsychires.2018.02.006
Garcia LS, Comim CM, Valvassori SS et al (2008) Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol 103:502–506. https://doi.org/10.1111/j.1742-7843.2008.00210.x
Girgenti MJ, Ghosal S, LoPresto D, Taylor JR, Duman RS (2017) Ketamine accelerates fear extinction via mTORC1 signaling. Neurobiol Dis 100:1–8. https://doi.org/10.1016/j.nbd.2016.12.026
Giustino TF, Maren S (2015) The role of the medial prefrontal cortex in the conditioning and extinction of fear. Front Behav Neurosci 9:298. https://doi.org/10.3389/fnbeh.2015.00298
Hayase T, Yamamoto Y, Yamamoto K (2006) Behavioral effects of ketamine and toxic interactions with psychostimulants. BMC Neurosci 7:25. https://doi.org/10.1186/1471-2202-7-25
Hirota K, Lambert DG (1996) Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth 77:441–444. https://doi.org/10.1093/bja/77.4.441
Holmes A, Singewald N (2013) Individual differences in recovery from traumatic fear. Trends Neurosci 36:23–31. https://doi.org/10.1016/j.tins.2012.11.003
Ito W, Erisir A, Morozov A (2015) Observation of distressed conspecific as a model of emotional trauma generates silent synapses in the prefrontal-amygdala pathway and enhances fear learning, but ketamine abolishes those effects. Neuropsychopharmacology 40:2536–2545
Kim S, Rush BS, Rice TR (2020) A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders. Eur Child Adolesc Psychiatry. https://doi.org/10.1007/s00787-020-01542-3
Knapska E, Macias M, Mikosz M et al (2012) Functional anatomy of neural circuits regulating fear and extinction. Proc Natl Acad Sci USA 109:17093–17098. https://doi.org/10.1073/pnas.1202087109
Koike H, Iijima M, Chaki S (2011) Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res 224:107–111. https://doi.org/10.1016/j.bbr.2011.05.035
Kos T, Popik P, Pietraszek M et al (2006) Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice. Eur Neuropsychopharmacol 16:297–310. https://doi.org/10.1016/j.euroneuro.2005.10.001
Li N, Lee B, Liu RJ et al (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959–964. https://doi.org/10.1126/science.1190287
Li N, Liu RJ, Dwyer JM et al (2011) Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69:754–761. https://doi.org/10.1016/j.biopsych.2010.12.015
Lin CH, Yeh SH, Leu TH, Chang WC, Wang ST, Gean PW (2003) Identification of calcineurin as a key signal in the extinction of fear memory. J Neurosci 23:1574–1579
Liriano F, Hatten C, Schwartz TL (2019) Ketamine as treatment for post-traumatic stress disorder: a review. Drugs Context 8:212305. https://doi.org/10.7573/dic.212305
Liu RJ, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK (2013) GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology 38:2268–2277. https://doi.org/10.1038/npp.2013.128
Ma XC, Dang YH, Jia M et al (2013) Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice. PLoS ONE 8:e56053. https://doi.org/10.1371/journal.pone.0056053
MacDonald JF, Miljkovic Z, Pennefather P (1987) Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 58:251–266. https://doi.org/10.1152/jn.19188.8.131.52
Maeng S, Zarate CA Jr (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9:467–474. https://doi.org/10.1007/s11920-007-0063-1
Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349–352. https://doi.org/10.1016/j.biopsych.2007.05.028
Maerckx C, Lombard CA, Tondreau T, Najimi M, Wallemacq P, Sokal EM (2016) Cyclosporine A disposition, hepatic and renal tolerance in Wistar rat. Immunopharmacol Immunotoxicol 38:390–394. https://doi.org/10.1080/08923973.2016.1233979
Mansuy IM (2003) Calcineurin in memory and bidirectional plasticity. Biochem Biophys Res Commun 311:1195–1208
Mansuy IM, Winder DG, Moallem TM, Osman M, Mayford M, Hawkins RD, Kandel ER (1998) Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 21:257–265. https://doi.org/10.1016/s0896-6273(00)80533-4
Maroun M, Richter-Levin G (2003) Exposure to acute stress blocks the induction of long-term potentiation of the amygdala-prefrontal cortex pathway in vivo. J Neurosci 23:4406–4409
McDonald AJ, Mascagni F, Guo L (1996) Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoagglutinin study in the rat. Neuroscience 71:55–75. https://doi.org/10.1016/0306-4522(95)00417-3
Milad MR, Quirk GJ (2002) Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420:70–74. https://doi.org/10.1038/nature01138
Mineur YS, Taylor SR, Picciotto MR (2014) Calcineurin downregulation in the amygdala is sufficient to induce anxiety-like and depression-like behaviors in C57BL/6J male mice. Biol Psychiatry 75:991–998. https://doi.org/10.1016/j.biopsych.2014.03.009
Mion G, Villevieille T (2013) Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther 19:370–380. https://doi.org/10.1111/cns.12099
Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921–2927
Nelson AJD, Cassaday HJ (2019) Data showing regional differences in rat brain monoaminergic function. Data Brief 27:104814. https://doi.org/10.1016/j.dib.2019.104814
Parise EM, Alcantara LF, Warren BL et al (2013) Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats. Biol Psychiatry 74:750–759. https://doi.org/10.1016/j.biopsych.2013.04.027
Park LT, Falodun TB, Zarate CA Jr (2019) Ketamine for Treatment-Resistant Mood Disorders. Focus (Am Psychiatr Publ) 17:8–12. https://doi.org/10.1176/appi.focus.20180030
Parsons RG, Ressler KJ (2013) Implications of memory modulation for post-traumatic stress and fear disorders. Nat Neurosci 16:146–153. https://doi.org/10.1038/nn.3296
Paxinos G, Watson C (2014) Paxino’s and Watson’s the rat brain in stereotaxic coordinates. Elsevier/AP, Academic Press is an imprint of Elsevier, Amsterdam
Pourmotabbed A, Mahmoodi G, Mahmoodi S, Mohammadi-Farani A, Nedaei SE, Pourmotabbed T, Pourmotabbed T (2014) Effect of central muscarinic receptors on passive-avoidance learning deficits induced by prenatal pentylenetetrazol kindling in male offspring. Neuroscience 279:232–237. https://doi.org/10.1016/j.neuroscience.2014.08.028
Rahimian R, Khoshneviszadeh M, Bahremand T, Zirak MR, Dehpour AR, Mousavizadeh K (2020) Oxytocinergic system mediates the proconvulsant effects of sildenafil: the role of calcineurin. Horm Behav 122:104753. https://doi.org/10.1016/j.yhbeh.2020.104753
Reus GZ, Carlessi AS, Titus SE et al (2015) A single dose of S-ketamine induces long-term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation. Dev Neurobiol 75:1268–1281. https://doi.org/10.1002/dneu.22283
Rosa AO, Lin J, Calixto JB, Santos AR, Rodrigues AL (2003) Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 144:87–93. https://doi.org/10.1016/s0166-4328(03)00069-x
Sato Y, Takayanagi Y, Onaka T, Kobayashi E (2007) Impact of cyclosporine upon emotional and social behavior in mice. Transplantation 83:1365–1370. https://doi.org/10.1097/01.tp.0000263332.65519.1f
Shalev A, Liberzon I, Marmar C (2017) Post-traumatic stress disorder. N Engl J Med 376:2459–2469. https://doi.org/10.1056/NEJMra1612499
Shaw JA, Matlovich N, Rushlow W, Cain P, Rajakumar N (2012) Role of calcineurin in inhibiting disadvantageous associations. Neuroscience 203:144–152. https://doi.org/10.1016/j.neuroscience.2011.12.010
Silvestre JS, Nadal R, Pallares M, Ferre N (1997) Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress Anxiety 5:29–33
Singewald N, Holmes A (2019) Rodent models of impaired fear extinction. Psychopharmacology 236:21–32. https://doi.org/10.1007/s00213-018-5054-x
Sistiaga A, Sanchez-Prieto J (2000) Protein phosphatase 2B inhibitors mimic the action of arachidonic acid and prolong the facilitation of glutamate release by group I mGlu receptors. Neuropharmacology 39:1544–1553. https://doi.org/10.1016/s0028-3908(00)00034-4
Vertes RP (2004) Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51:32–58. https://doi.org/10.1002/syn.10279
von Horsten S, Exton MS, Voge J et al (1998) Cyclosporine A affects open field behavior in DA rats. Pharmacol Biochem Behav 60:71–76. https://doi.org/10.1016/s0091-3057(97)00467-x
Womble AL (2013) Effects of ketamine on major depressive disorder in a patient with posttraumatic stress disorder. AANA J 81:118–119
Yang C, Yang J, Luo A, Hashimoto K (2019) Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites. Transl Psychiatry 9:280. https://doi.org/10.1038/s41398-019-0624-1
Yilmaz A, Schulz D, Aksoy A, Canbeyli R (2002) Prolonged effect of an anesthetic dose of ketamine on behavioral despair. Pharmacol Biochem Behav 71:341–344. https://doi.org/10.1016/s0091-3057(01)00693-1
Yu JJ, Zhang Y, Wang Y, Wen ZY, Liu XH, Qin J, Yang JL (2013) Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. Psychopharmacology 225:361–372. https://doi.org/10.1007/s00213-012-2823-9
Zeng H, Chattarji S, Barbarosie M et al (2001) Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107:617–629. https://doi.org/10.1016/s0092-8674(01)00585-2
Zhang LM, Zhou WW, Ji YJ et al (2015) Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder. Psychopharmacology 232:663–672. https://doi.org/10.1007/s00213-014-3697-9
The content of this paper is extracted from the Pharm. D thesis submitted by Negin Tamasoki which was financially supported (Grant no. 980137) by the Deputy for Research and Technology of Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Animal experiment protocols were approved by the local ethical committee (ethical code, IR.KUMS.1397.849).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Communicated by Sreedharan Sajikumar.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Mohammadi-Farani, A., Tamasoki, N. & Rahimian, R. Intra-prefrontal cyclosporine potentiates ketamine-induced fear extinction in rats. Exp Brain Res 239, 1401–1415 (2021). https://doi.org/10.1007/s00221-021-06050-7
- Medial prefrontal cortex
- Fear extinction